You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

The costs of cancer drugs

Clinical Trials

Impact Factor: 2.2 / 5-Year Impact Factor: 2.3

Journal Homepage Submission guidelines

Restricted access

Editorial

First published online April, 2020

The costs of cancer drugs

Volume 17, Issue 2

https://doi.org/10.1177/1740774520907662

Abstract

Get full access to this article

View all access options for this article.

References

1.

Hsiue

EHC

Moore

T

Caleb

AG

. Estimated costs of pivotal trials for U.S. Food and Drug Administration approved cancer drugs, 2015-2017. Clin Trials 2020; 17(2): 119–12.

2.

Bach

PB

. Cost savings and data limitations of new cancer drug studies. Clin Trials 2020; 17(2): 126–128.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Design of the Jerusalem Handwashing Study: meeting the challenges of a preschool-based public health intervention trial

Retricted access

Parametric conditional frailty models for recurrent cardiovascular events in the lipid study

Retricted access

Recognizing chronological bias for what it is

Retricted access

Feasibility of randomized controlled trials on seclusion and mechanical restraint